How will the Biden administration affect funding for life science research?
Biotech Voices is a collection of exclusive opinion editorials from some of the leading voices in biopharma on the biggest industry questions today. Think you have a voice that should be heard? Reach out to Amber Tong.
The advent of a new administration in Washington often portends major changes in budgeting and spending, and thus it will be in the administration of Joe Biden, if he adheres to the 2020 Democratic Party platform.
But one thing that is not likely to change is the ongoing uptick in funding for research in the life sciences — particularly the funding for the National Institutes of Health, the Centers for Disease Control, and other federal agencies focused on life science research.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.